MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Patient Experience and Satisfaction With Once-Daily Deutetrabenazine Extended-Release Tablets for Treatment of Huntington Disease-Related Chorea

    B. Bulica, M. Konings, S. Thompson, A. Yang, S. Kotak, P. Gandhi (Detroit, USA)

    Objective: Objectives of this study were to explore patient-reported ease of use, effectiveness, and satisfaction during real-world use of once-daily (QD) deutetrabenazine extended-release tablets in…
  • 2025 International Congress

    Comparative Efficacy and Safety of VMAT2 Inhibitors for Chorea in Huntington’s Disease: A Systematic Review and Meta-Analysis

    A. Abunamoos, M. Mustafa, F. Alnajjar, Y. Aljazi, K. Moghib, N. Hamam, M. Alghaniem (Amman, Jordan)

    Objective: To assess the safety and efficacy of vesicular monoamine transporter 2 (VMAT2) inhibitors (deutetrabenazine, tetrabenazine, valbenazine) in managing chorea in Huntington’s Disease (HD). Background:…
  • 2025 International Congress

    MS-Related Tremor in a Patient with Multiple Sclerosis Treated with Thermal Ablation of the Left Ventral Intermediate (VIM) Thalamic Nucleus: The Role of Tractography-Guided Targeting

    F. Fenner, E. da Silva, W. Morikawa, E. Gisoldi, A. Venturi, G. Chung (Sao Paulo, Brazil)

    Objective: To present a case of kinetic-postural tremor secondary to multiple sclerosis (MS) successfully treated with tractography-guided thermal ablation of the left dentatorubrothalamic tract (DRT)…
  • 2025 International Congress

    Demographic Analysis of Patients with Essential Tremor (ET)

    N. Aripova, L. Kenjaeva, B. Bakhtiyor, Y. Nishonova (Tashkent, Uzbekistan)

    Objective: The objective of this study is to analyze the demographic characteristics of patients diagnosed with Essential Tremor (ET), focusing on age distribution and gender…
  • 2025 International Congress

    Assessment of Quality of Life in Patients with Hemifacial Spasm: Preliminary Report of a Case-Control Study

    N. Durmaz Celik, N. Garipcin, E. Tatlı, M. Kuzu Kumcu, S. Ozkan (Eskisehir, Turkey)

    Objective: This study aims to assess the impact of HFS on quality of life by comparing physical, psychological, social, and environmental well-being between HFS patients…
  • 2025 International Congress

    Clinical and paraclinical aspects of extrapyramidal disorders in patients with cerebrovascular pathology

    S. Jumanazarova, R. Matmurodov, E. Abduqodirov, A. Kalanov, S. Mamatova (Tashkent, Uzbekistan)

    Objective: To study of clinical and paraclinical aspects of extrapyramidal disorders in patients with cerebrovascular pathology Background: A considerable proportion of patients with chronic cerebral…
  • 2025 International Congress

    Chorea-acanthocytosis in Puerto Rico: A Case Series

    E. Pérez-Luciano, C. Chapel-Crespo, D. Lozada-Figueroa, I. Pita-García, L. Surillo-Dahdah (Ponce, Puerto Rico)

    Objective: To describe three unrelated cases of Chorea-acanthocytosis (ChAc) from Puerto Rico, featuring heterozygous and homozygous pathogenic variants Background: ChAc, a rare autosomal recessive neurodegenerative…
  • 2025 International Congress

    Unraveling NKX2-1-related disorders: clinical, genetic, and neuroimaging insights from a global cohort

    JD. Ortigoza-Escobar, L. Nou-Fontanet, C. Ravelli, S. Balsells Mejia, E. Roman Schiffels, A. Innocenti, B. Villafuerte, A. Salazar, V. Quiroz, A. Sariego Jamardo, G. Bonato, A. Díaz-Gomez, A. Afenjar, C. Vilain, P. Dumke Dasilva, D. Garcia-Navas Nuñez, M. Krygier, MJ. Molnar, L. Milanowski, K. Ounap, M. Pauni, R. Borie, P. Vega, M. Villamil, S. Yilmaz, D. Zádori, M. Zawadzka, TS. Barakat, N. Sebastian, D. Natera Debenito, L. Soliani, CM. de Gusmao, G. Garone, N. Specchio, M. Carecchio, JC. Moreno, F. Magrinelli, D. Ebrahimi-Fakhari, C. Castiglioni, M. Kurian, JN. Carvalho, R. Pons, E. Flamand-Roze, D. Doummar (Barcelona, Spain)

    Objective: To analyze the clinical spectrum, genotype-phenotype correlations, and prognostic factors in NKX2-1-related disorders (NKX2-1-RD) through a multicenter study, providing insights for improved diagnosis and…
  • 2025 International Congress

    Efficacy of Clonidine for Tourette Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials

    Y. Aljazi, A. Abunamoos, F. Alnajjar, M. Mustafa, J. Al-Tarawneh, L. Aldaher, M. Alghaniem (Amman, Jordan)

    Objective: To evaluate the efficacy of Clonidine in reducing tic severity and improving global clinical outcomes in patients with Tourette syndrome. Background: Tourette syndrome is a neurodevelopmental disorder…
  • 2025 International Congress

    From syndrome to genetics: Genetic Etiologies of Dystonia with Anarthria/Aphonia

    A. Menetrey, E. Rayco, M. Emamikhah Abarghouei, A. Lang, C. Gorodetsky, C. Ganos (Toronto, Canada)

    Objective: This study provides a comprehensive list of genetic causes in a large cohort of 53 pediatric and adult patients with dystonia and anarthria or…
  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley